Literature DB >> 24129045

Desensitization of darbepoetin-α: a case report.

F Tahan1, H H Akar, I Dursun, K Yilmaz.   

Abstract

Human recombinant erythropoietins (EPO) and darbepoetins are widely used for anemias associated with chronic kidney disease.  Allergic reactions to erythropoetins and darbepoetins have only occasionally been reported. These skin reactions include pruritus, wheals at the injection site, orofacial anaphylaxis and anjioedema. In this article, we report an 11 year-old female who experienced generalized   erithematous skin eruption and desquamation after both erythropoietin and darbepoetin treatments.  We successfully used darbepoetin with the support of premedication and desensitization.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24129045

Source DB:  PubMed          Journal:  Eur Ann Allergy Clin Immunol        ISSN: 1764-1489


  1 in total

1.  A novel outpatient desensitization protocol for recombinant human erythropoietin allergy in a pediatric patient.

Authors:  Jaime S Rosa; Van B Vuong; Orly Haskin; Anne Y Liu
Journal:  Allergy Asthma Clin Immunol       Date:  2018-03-12       Impact factor: 3.406

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.